|
Additional information was added to d9, h3, h4, h6, and h11: h4: the lot was manufactured between february 27, 2024 ¿ february 28, 2024.H11: the device and photo sample were received for evaluation.Visual inspection of the returned sample and photo sample did not identify any abnormalities that could have contributed to the reported condition.Functional testing was performed, and a leak was observed from the administration spike port bonding area.The reported condition was verified.The cause of the condition could not be determined; however, the most probable cause was due to inadequate or lack for cyclohexanone applied to the spike port cap tube when it was inserted into the spike port during the manufacturing process.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|